BACKGROUND Since the advent of the 20th century,alongside the progression of medical science and technological advancements,immunotherapy has emerged as a pivotal thera-peutic approach for tumor patients subsequent to...
Background: The effects of radiation therapy can impact patients’ quality of life, leading to treatment interruptions and therefore sub-optimal outcomes. The main aim was to evaluate the preliminary effects of Ocoxin...
supported by the National Natural Science Foundation of China(Grant Nos.82073439 and 82373475).
Dear Editor,Acrodermatitis continua of Hallopeau(ACH),a rare and chronic variant of pustular psoriasis,is characterized by atrophic skin changes,sterile pustules,onychodystrophy,and osteolysis of the distal phalanges ...
supported by grants from the National Key Research&Development Program of China(Nos.2021YFC2701704 and 2021YFC2701700);the National Natural Science Foundation of China(Nos.81971433,82271749,and 82201905);Project of the Science and Technology Bureau of Sichuan Province(No.2023NSFSC0544);the Fundamental Research Funds for the Central University(No.SCU2023D006)
To the Editor:Atopic dermatitis(AD)is the most common chronic allergic skin disease worldwide.House dust mite(HDM)is the most prevalent aeroallergen and pathogenic cause,which triggers skin barrier disruption and poly...
supported by the Beijing Municipal Natural Science Foundation(7202139 and 7162137),China.
Skin Exposure of skin to ionizing radiation can induce acute or chronic biological effects,resulting in radiation-induced skin injury(RSI).Premature cellular senescence,caused by oxidative stress and/or DNA damage fro...
approved by the Ethics Committee of Central South University(ethics approval number:202212806);registered with the Chinese Clinical Trials Registry(chictr.org.cn,registration number:ChiCTR2300076625).
Dear Editor,Upadacitinib and abrocitiniboareselective,smallmolecule Janus kinase 1(JAK1)inhibitors approved in China for the treatment of moderate-to-severe atopic dermatitis(AD)[1].The favorable efficacy and tolerabl...
To the Editor:Atopic dermatitis(AD)is a chronic inflammatory skin disorder with a relapsing-remitting disease course that warrants flexible dosing.[1,2]In China,abrocitinib,an oral,once-daily,Janus kinase 1-selective ...